RxDoctor Payments Data

Amber Fowler, MD

MOHS-Micrographic Surgery · Mount Vernon, WANPI 1093733495

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $391, more than ten times the $26 reported in 2019. That places this record below the midpoint for mohs-micrographic surgery clinicians in WA, where the typical reported total is $1,261.

$1,109in general payments, 2019–2025

Across 47 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$212
  • Regeneron Healthcare Solutions, Inc.$181
  • Sun Pharmaceutical Industries Inc.$146
  • Boehringer Ingelheim$130
  • AbbVie$122
  • Johnson & Johnson$78
  • plus $240 from 10 others

What the payments were for

  • Food & beverage$1,00991%
  • Education$1009%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,109 in reported general payments places this provider in the 45th percentile of 38 mohs-micrographic surgery providers in Washington.

See all mohs-micrographic surgery providers in Washington

Medicare billing

Part B allowed, 2024
$720,757
Medicare patients
1,189
Services billed
13,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast11$62,174
Fluorouracil94$5,713
Metronidazole107$5,193
Clobetasol Propionate89$5,069
Ketoconazole144$2,446
Mupirocin198$1,659
Fluocinonide37$1,513
Doxycycline Hyclate87$1,352
Clindamycin Phosphate36$1,286
Triamcinolone Acetonide108$1,116
Ciclopirox40$1,091
Ammonium Lactate38$1,001
Betamethasone Dipropionate18$605
Desonide16$579
Econazole Nitrate11$442

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Mount Vernon

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →